ARCHIVES

Guideline Revisions or Outstanding Investigator Grant Still Controversial

This article is from The Cancer Letter archive.

Vol. 09 No. 47 | December 9, 1983

Download PDF Visit The Full Archive

Related Articles

“Our Job Is to Be The One Agency That Speaks To Cancer”

October 28, 1994

Natcher: Multiple Year Funding Would Not be Approved If Presented As Request For Reprogramming

March 22, 1985

AACR Opposes Human Life Bill; ASCO Backs Cancer Act, Reimbursement

May 8, 1981

DCCP Board Approves Concept Of RFA, New, Competing Contracts

October 15, 1982

Workers Ignorant Of Benzidine Risk, Union tells Congress

April 3, 1987

NCI Gets Withheld Funds; Hazleton Tops List In Stepped-Up Award Flow

April 4, 1975